Menu Close

Selected Abstracts

Please find below the list of selected abstract for the ILC Symposium 2024.

Abstract IDFirst nameLast NameInstitute or Affiliation:Abstract Title:
ORALWilliamYangInstitute of Cancer ResearchE-cadherin/Aurora-A kinase inhibitor synthetic lethality highlights novel therapeutic vulnerabilities for targeting metastatic lobular breast cancer.
ORALEduardoPenaKing’s College LondonInsights into the Transcriptomic and Immune Heterogeneity of Pleomorphic Invasive Lobular Breast Cancer
ORALGitteZelsKU LeuvenClinical and histopathological characterisation of metastatic invasive lobular breast cancer: lessons learned from post-mortem tissue donation programs
ORALSanaShabbirUniversity of EdinburghRole of Interleukin-6 in regulating estrogen signaling and endocrine therapy resistance in Invasive Lobular Carcinoma
ORALInsaThaleUniversity of PittsburghCharacterization of a Syngeneic ER+ Mouse Model Representing Invasive Lobular Breast Carcinoma
ORALAbdallaWednWomen’s Cancer Research Center, Magee Women’s Research Institute, UPMC Hillman Cancer Center, Pittsburgh, PA, USAHypomethylation and over-expression of AP2b in ILC causes increased growth due to effects on cell cycle
POSTER-01GuilhermeNader MartaDana-Farber Cancer InstituteSubtype-specific prognostic value of lobular histology in patients with early-stage breast cancer: a nationwide population-based study
POSTER-02LounesDjerroudiInstitut CurieClinico-pathological Characteristics of Breast Invasive Lobular Carcinoma in non-CDH1 genetic predisposition. Experience from the Institut Curie.
POSTER-03MatteoSerraInstitut Jules BordetSpatial Transcriptomics-Derived Classification of Invasive Lobular Carcinoma: Associations with Clinical, Genomic Characteristics, and Prognosis
POSTER-04AzimeAKÇAÖZ-ALASARIzmir Institute of TechnologyANALYSIS OF m6A RNA MODIFICATION PATTERNS IN INVASIVE LOBULAR BREAST CANCER
POSTER-05AereeKimKorea University Guro HospitalComprehensive characterization of invasive mammary carcinoma with lobular features: Integrating morphology and E-cadherin immunochemistry pattern
POSTER-06KarenVan BaelenKU LeuvenClinical challenges and proposed solutions for invasive lobular breast cancer
POSTER-07AzadehNasrazadaniMD Anderson Cancer CenterInvasive lobular carcinoma is rarely seen in inflammatory breast cancer and confers an inferior prognosis.
POSTER-08EsmeBullockUniversity of EdinburghCancer-associated fibroblast driven paracrine IL-6/STAT3 signalling promotes migration and dissemination of Invasive Lobular Carcinoma cells.   
POSTER-09NaomiEastwoodUniversity of ManchesterDeciphering the Transcription Factor Network and Enhancer Activity Controlled by ARID1A in Lobular Cancers
POSTER-10JagmohanHoodaUniversity of PittsburghEstablishing a Comprehensive Living Biobank of ILC Patient-Derived Organoids to Advance Breast Cancer Research
POSTER-11MorganCodyUniversity of Pittsburgh School of MedicineIs there mis and/or late diagnosis of metastatic ILC? A quantitative and qualitative analysis
POSTER-12SumayyaAbdul QadirUniversity of TorontoDeveloping and Characterizing Models for Recurrent Invasive Lobular Breast Carcinoma with Nf1 and HER2/Neu Mutations
POSTER-13LauraKennedyVanderbilt University Medical CenterTargeted Neoadjuvant Treatment Trial for HER2-mutated Lobular Breast Cancer (Trial in Progress)
POSTER-14Chinasa AUfonduDepartment of Pharmacology, Molecular Pharmacology and Therapeutics (MPaT), University of Minnesota, Twin Cities.Unique interactions between E-cadherin loss and Estrogen receptor drive tumorigenesis in Invasive Lobular Cancer.
POSTER-15Jie BinLiuUniversity of PittsburghDestabilizing HER2 with Neratinib or Ganetespib Enhances Preclinical Efficacy of Trastuzumab Deruxtecan in HER2-mutant Invasive Lobular Breast Cancer
POSTER-16AnneVincent-SalomonInstitut CurieBreast cancer subtypes: a patient’s survey with a special focus on lobular breast cancer
POSTER-17LaurieHutchesonLobular Breast Cancer Alliance Inc.Worldwide Collaboration Among Invasive Lobular Carcinoma Researchers and Patient Advocates Produces October 15th Global Lobular Breast Cancer Awareness Day
POSTER-18ClaireTurnerLobular Breast Cancer UKChanging UK Breast Cancer Treatment Guidelines

Authors: Helen Coulthard1, Sara MacLennan2, Claire Turner3,
1. De Montfort University & Lobular Breast
POSTER-19HelenCoulthardDe Montfort UniversityThe co-creation of digital postcards to support those with an Invasive Lobular Carcinoma
diagnosis